Literature DB >> 12810162

Analytical evaluation of hemoglobin A(1c) dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients.

Majid Y Moridani1, Zul Verjee, Lynn C Allen.   

Abstract

OBJECTIVES: To evaluate the analytical performance of the Bio-Rad Variant II HbA(1c) dual kit assay. DESIGN AND METHODS: Precision, carryover, linearity and analytical range were investigated. 139 patients' HbA(1c) results analyzed by the Variant II were compared to the Variant I method. 49 blood samples analyzed by the Variant II at Toronto Medical Laboratories (TML) were compared to the Variant II at Hospital for Sick Children (HSC).
RESULTS: Total imprecision was less than 2% for the Variant II assay. The method had a wide analytical range with no carryover. HbA(1c) results were not changed after switching back and forth from the beta thalassemia to HbA(1c) assay. The Variant II showed an average of 0.0027 negative bias compared to the Variant I method. There was an average of 0.0020 negative bias for HbA(1c) results on the Variant II at TML compared to the Variant II at HSC.
CONCLUSIONS: HbA(1c) analysis on the Variant II HbA(1c) dual kit is a relatively fast and reproducible method.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810162     DOI: 10.1016/s0009-9120(03)00013-4

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Comparison of Arkray/ELITech ADAMS HA-8180V with Bio-Rad Variant, II Turbo2.0 and Tosoh Bioscience HLC-723G8 for HbA1c determination.

Authors:  Stéphanie Badiou; Julie Guillot; Nils Kuster; Anne-Sophie Bargnoux; Patricia Aguilar-Martinez; Elodie Boissier; Jean-Paul Cristol; Anne-Marie Dupuy
Journal:  J Clin Lab Anal       Date:  2014-03-20       Impact factor: 2.352

2.  Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes.

Authors:  Heather F de Vries McClintock; Knashawn H Morales; Dylan S Small; Hillary R Bogner
Journal:  Behav Med       Date:  2014-10-10       Impact factor: 3.104

3.  Neighborhood social environment and patterns of adherence to oral hypoglycemic agents among patients with type 2 diabetes mellitus.

Authors:  Heather F de Vries McClintock; Douglas J Wiebe; Alison J OʼDonnell; Knashawn H Morales; Dylan S Small; Hillary R Bogner
Journal:  Fam Community Health       Date:  2015 Apr-Jun

4.  Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial.

Authors:  Hillary R Bogner; Knashawn H Morales; Heather F de Vries; Anne R Cappola
Journal:  Ann Fam Med       Date:  2012 Jan-Feb       Impact factor: 5.166

5.  Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.

Authors:  P Katulanda; B Shine; G W Katulanda; A Silva; E L Asfir; R Sheriff; N Somasundaram; A E Long; P J Bingley; M I McCarthy; A Clark; D R Matthews
Journal:  Diabetologia       Date:  2008-06-05       Impact factor: 10.122

6.  A brief adherence intervention that improved glycemic control: mediation by patterns of adherence.

Authors:  Heather F de Vries McClintock; Knashawn H Morales; Dylan S Small; Hillary R Bogner
Journal:  J Behav Med       Date:  2014-06-10

7.  Labile glycated haemoglobin and carbamylated haemoglobin are still critical points for HbA1c measurement.

Authors:  Aurore Desmons; Stéphane Jaisson; Nathalie Leroy; Philippe Gillery; Emmanuelle Guillard
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

8.  Measuring concurrent oral hypoglycemic and antidepressant adherence and clinical outcomes.

Authors:  Hillary R Bogner; Heather F de Vries; Alison J O'Donnell; Knashawn H Morales
Journal:  Am J Manag Care       Date:  2013-03-01       Impact factor: 2.229

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.